Bioenergetic immunostimulation, metabolism, and nutrition support in lung cancer: a case study

The most common type of cancer [Ca]in the USA is lung Ca, where it contributes to >; 150,000 deaths annually despite many advances in early diagnosis and treatment modalities. The patient was a 64 y.o. WM, no prior Hx of Ca or other major illness. Patient underwent lobectomy of a 5.4 cm mass R lung which confirmed Ca, followed by a vigorous bioenergetics regimen including Nutritional [macrobiotic: 65% mixed grains, 20% mixed veg, 15% fruits, exercise [<800 m swimming daily], and maintaining a positive attitude. Pt resumed full time work after 2 w, and remains Ca‐free and in excellent health at 7 y followup. Conclusion Patients require adequate nutritional, physical and emotional Rx following lobectomy for lung Ca. Bioenergic Rx may result in improved CD4, CD25, & T cell function and decrease mortality & improve survival in Lung Ca. Institutional Support.